BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024 PressReach · Nov 17, 2024
Sing for Hope founding board member and arts-in-health champion Renée Fleming welcomes Dr. Roopa Kalyanaraman Marcello as Chief of Public Health Innovation PressReach · Nov 16, 2024
Tampa General and USF Health to Bring World's Most Precise Robotic Surgical Technology to Florida PressReach · Nov 16, 2024
The Electronic Health Records Market is set to grow by USD 54.7 billion from 2024-2028, with the benefits of EHR driving adoption and boosting revenue. Report on how AI is reshaping the market landscape - Technavio PressReach · Nov 16, 2024
Herman Law Achieves Key Ruling in Child Sexual Abuse Cases Against the Roman Catholic Diocese of Brooklyn PressReach · Nov 16, 2024
Regenerative Medicine Market to grow by USD 70.11 Billion (2024-2028), rising prevalence of chronic diseases to drive revenue, Report with AI-powered insights - Technavio PressReach · Nov 16, 2024
Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation PressReach · Nov 16, 2024
Immunovia presents model-development study results at meeting of the Collaborative Group of the Americas--Inherited Gastrointestinal Cancers PressReach · Nov 15, 2024
Foresee Pharmaceuticals Receives the Second Positive Recommendation from DSMB to Continue the Casppian Study, a Phase 3 Clinical Trial of Leuprolide (FP-001) Injectable Emulsion for the Treatment of Central Precocious Puberty PressReach · Nov 15, 2024
International Cancer Organizations Present Collaborative Work During Oncology Event in China PressReach · Nov 15, 2024
